ALPS Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190K | Sell |
14,619
-5,330
| -27% | -$69.3K | ﹤0.01% | 1009 |
|
|
2025
Q1 | $211K | Sell |
19,949
-1,952
| -9% | -$20.7K | ﹤0.01% | 959 |
|
|
2024
Q4 | $372K | Buy |
21,901
+63
| +0.3% | +$1.07K | ﹤0.01% | 741 |
|
|
2024
Q3 | $507K | Sell |
21,838
-8,277
| -27% | -$192K | ﹤0.01% | 608 |
|
|
2024
Q2 | $733K | Buy |
30,115
+2,102
| +8% | +$51.2K | 0.01% | 520 |
|
|
2024
Q1 | $946K | Sell |
28,013
-207
| -0.7% | -$6.99K | 0.01% | 502 |
|
|
2023
Q4 | $890K | Sell |
28,220
-2,103
| -7% | -$66.3K | 0.01% | 510 |
|
|
2023
Q3 | $775K | Buy |
30,323
+10,799
| +55% | +$276K | 0.01% | 528 |
|
|
2023
Q2 | $560K | Buy |
+19,524
| New | +$560K | ﹤0.01% | 592 |
|
|
2022
Q4 | – | Sell |
-14,481
| Closed | -$215K | – | 1027 |
|
|
2022
Q3 | $215K | Sell |
14,481
-1,196
| -8% | -$17.8K | ﹤0.01% | 997 |
|
|
2022
Q2 | $247K | Sell |
15,677
-11,425
| -42% | -$180K | ﹤0.01% | 950 |
|
|
2022
Q1 | $731K | Sell |
27,102
-3,403
| -11% | -$91.8K | 0.01% | 343 |
|
|
2021
Q4 | $1.13M | Sell |
30,505
-1,754
| -5% | -$64.9K | 0.01% | 346 |
|
|
2021
Q3 | $1.54M | Sell |
32,259
-2,406
| -7% | -$115K | 0.01% | 346 |
|
|
2021
Q2 | $1.17M | Buy |
+34,665
| New | +$1.17M | 0.01% | 385 |
|
|
2020
Q4 | – | Sell |
-31,101
| Closed | -$1.33M | – | 839 |
|
|
2020
Q3 | $1.33M | Buy |
31,101
+3,148
| +11% | +$135K | 0.02% | 292 |
|
|
2020
Q2 | $1.31M | Buy |
+27,953
| New | +$1.31M | 0.02% | 275 |
|